Orsiro

DEVICE8 trials

Sponsors

Deutsches Herzzentrum Muenchen, Foundation of Cardiovascular Research and Education Enschede, Biotronik UK Ltd., Thorax Centrum Twente, Insel Gruppe AG, University Hospital Bern

Conditions

Acute Coronary SyndromeAcute Myocardial InfarctionAngina PectorisAngina, UnstableCoronary Artery DiseaseCoronary Artery DiseasesCoronary Heart DiseaseCoronary Restenosis

Phase 4

ORSIRO Stents Versus Xience PRIME Stents Assessed by Optical Coherence Tomography

CompletedNCT01594736

Deutsches Herzzentrum MuenchenCoronary Heart Disease

Start: 2012-04-30End: 2013-06-30Updated: 2017-08-04

BIOFREEDOM Stent Versus ORSIRO Stent: SORT OUT IX

Odense University HospitalIschaemic Heart Disease

Start: 2015-12-31End: 2023-10-31Target: 3150Updated: 2020-09-18

Unknown Phase

Comparison of BIOdegradable Polymer and DuRablE Polymer Drug-eluting Stents in an All COmeRs PopulaTion (BIO-RESORT)

CompletedNCT01674803

Foundation of Cardiovascular Research and Education EnschedeAcute Coronary Syndrome, Angina Pectoris, Angina, Unstable +4

Start: 2012-12-21End: 2020-08-25Updated: 2022-07-20

BIOFLOW-III UK Satellite Registry Orsiro Stent System

Biotronik UK Ltd.Coronary Artery Diseases

Start: 2015-11-30End: 2018-12-31Target: 500Updated: 2017-10-02

Bioresorbable Polymer ORSIRO Versus Durable Polymer RESOLUTE ONYX Stents

Thorax Centrum TwenteAcute Coronary Syndrome, Angina Pectoris, Coronary Artery Disease +3

Start: 2016-10-07End: 2019-03-31Updated: 2017-02-03

A Comparison of an Ultrathin Strut Biodegradable Polymer Sirolimus-Eluting Stent With a Durable Polymer Everolimus-Eluting Stent for Patients With Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

CompletedNCT02579031

Insel Gruppe AG, University Hospital BernAcute Coronary Syndrome, Coronary Artery Disease

Start: 2016-04-30End: 2020-05-31Updated: 2020-09-02

The SORT OUT IX STEMI OCT Trial

Odense University HospitalAcute Myocardial Infarction

Start: 2016-09-30End: 2023-09-30Target: 80Updated: 2020-09-21

SORT OUT X - Combo Stent Versus ORSIRO Stent

Active, not recruitingNCT03216733

Aarhus University Hospital SkejbyAngina Pectoris, Coronary Heart Disease, Myocardial Infarction

Start: 2017-06-01End: 2028-12-31Updated: 2023-11-28

Related Papers

Impact of diabetes on three-year outcome after coronary stenting in patients with polyvascular atherosclerotic disease - a secondary analysis of the randomized TWENTE trials.

2025-07-061 citations

Elderly patients treated with Onyx versus Orsiro drug-eluting coronary stents in a randomized clinical trial with long-term follow-up.

2025-03-04

Clinical outcome after bleeding events following coronary stenting in patients with and without comorbid peripheral arterial disease

Cardiovascular Intervention and Therapeutics2024-12-195 citations

Premature coronary artery disease in all-comers undergoing first PCI

European Heart Journal2023-11-01

Dual-therapy CD34 antibody-covered sirolimus-eluting COMBO stents versus sirolimus-eluting Orsiro stents in patients treated with percutaneous coronary intervention: the three-year outcomes of the SORT OUT X randomised clinical trial

EuroIntervention2023-10-016 citations

First myocardial infarction in patients with premature coronary artery disease: insights into patient characteristics and outcome after treatment with contemporary stents

European Heart Journal Acute Cardiovascular Care2023-08-224 citations

Outcome of percutaneous coronary intervention using ultrathin-strut biodegradable polymer sirolimus-eluting versus thin-strut durable polymer zotarolimus-eluting stents in patients with comorbid peripheral arterial disease: a post-hoc analysis from two randomized trials

Cardiovascular Diagnosis and Therapy2023-08-012 citations

Impact of premature coronary artery disease on adverse event risk following first percutaneous coronary intervention

Frontiers in Cardiovascular Medicine2023-06-195 citations

Ultrathin-strut vs thin-strut drug-eluting stents for multi and single-stent lesions: A lesion-level subgroup analysis of 2 randomized trials

American Heart Journal2023-05-153 citations

Complex primary percutaneous coronary intervention with ultrathin‐strut biodegradable versus thin‐strut durable polymer drug‐eluting stents in patients with ST‐segment elevation myocardial infarction: A subgroup analysis from the BIOSTEMI randomized trial

Catheterization and Cardiovascular Interventions2023-02-192 citations

Final 5‐Year Report of the Randomized BIO‐RESORT Trial Comparing 3 Contemporary Drug‐Eluting Stents in All‐Comers

Journal of the American Heart Association2022-11-0829 citations

Clinical outcome up to 2 years after percutaneous coronary intervention in all-comers with concomitant symptomatic peripheral arterial disease: a pooled analysis in 9,204 randomized trial participants

European Heart Journal2022-10-01

Impact of prediabetes and diabetes on 3-year outcome of patients treated with new-generation drug-eluting stents in two large-scale randomized clinical trials

Cardiovascular Diabetology2021-10-3026 citations

First Report of 3-Year Clinical Outcome After Treatment With Novel Resolute Onyx Stents in the Randomized BIONYX Trial.

2021-07-1319 citations

Multivessel percutaneous coronary intervention with thin-strut biodegradable versus durable polymer drug-eluting stents in ST-segment elevation myocardial infarction: A subgroup analysis of the BIOSTEMI randomized trial.

2021-04-203 citations

Randomized Clinical Comparison of the Dual-Therapy CD34 Antibody-Covered Sirolimus-Eluting Combo Stent With the Sirolimus-Eluting Orsiro Stent in Patients Treated With Percutaneous Coronary Intervention: The SORT OUT X Trial

Circulation2021-04-0739 citations

Acute myocardial infarction treated with novel Resolute Onyx and Orsiro stents in the randomized BIONYX trial

Catheterization and Cardiovascular Interventions2021-03-105 citations

Biodegradable- Versus Durable-Polymer Drug-Eluting Stents for STEMI

JACC: Cardiovascular Interventions2021-03-0155 citations

Biodegradable polymer sirolimus-eluting stents vs durable polymer everolimus-eluting stents in patients undergoing percutaneous coronary intervention: A meta-analysis of individual patient data from 5 randomized trials.

2021-02-1716 citations

Diabetic patients treated with novel thin composite-wire strut zotarolimus-eluting stents versus ultrathin strut sirolimus-eluting stents in the BIONYX trial: 2-year results of a prespecified analysis

European Heart Journal2020-11-01

18 more papers not shown